A Molecular Epidemiology Study in Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) of Adeno Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
N/A
20 Years
N/A
20 Years
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer
Both
Non Small Cell Lung Cancer
Trial Information
A Molecular Epidemiology Study in Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) of Adeno Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to
assess EGFR mutation status.
Inclusion Criteria:
- Histological or cytologically confirmed advanced Non small cell lung cancer of adeno
histology NSCLC treatment naive Availability of cancer tissue or cytology sample
Exclusion Criteria:
- Involvement in the planning and/or conduct of the study Previous enrollment in the
present study
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
Outcome Measure:
EGFR mutation status of Asian patients with advanced NSCLC
Outcome Time Frame:
Samples will be tested after informed consent. Mutation results will be available within 1-3 weeks.
Safety Issue:
No
Principal Investigator
Guy Yeoman, MBBS, MFPM
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca
Authority:
China: Ethics Committee
Study ID:
D7913L00086
NCT ID:
NCT01185314
Start Date:
September 2010
Completion Date:
July 2011
Related Keywords:
- Non Small Cell Lung Cancer
- NSCLC, EGFR mutation
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
